Literature DB >> 16982787

Prevalence of mutations associated with higher levels of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Car Nicobar Island and Assam, India.

Anwar Ahmed1, Vanshika Lumb, Manoj K Das, Vas Dev, Yagya D Sharma.   

Abstract

To assess sulfadoxine and pyrimethamine resistance (SPR), we describe here the dihydropteroate synthetase (DHPS) mutations among the Plasmodium falciparum isolates in which dihydrofolate reductase (DHFR) mutations had recently been described by us (A. Ahmed, M. K. Das, V. Dev, M. A. Saifi, Wajihullah, and Y. D. Sharma, Antimicrob. Agents Chemother. 50:1546-1549, 2006). A majority of isolates from Car Nicobar island showed double DHPS mutations, whereas a majority of isolates from Uttar Pradesh (U.P.) and Assam contained the wild-type DHPS. Based on DHFR-DHPS mutations, the expected level of SPR was lowest in U.P., higher in Assam, and highest in Car Nicobar, suggesting that a region-wise drug policy is needed in India.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982787      PMCID: PMC1635222          DOI: 10.1128/AAC.00732-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.

Authors:  James G Kublin; Fraction K Dzinjalamala; Deborah D Kamwendo; Elissa M Malkin; Joseph F Cortese; Lisa M Martino; Rabia A G Mukadam; Stephen J Rogerson; Andres G Lescano; Malcolm E Molyneux; Peter A Winstanley; Phillips Chimpeni; Terrie E Taylor; Christopher V Plowe
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

Review 2.  Drug resistance in malaria.

Authors:  W Peters
Journal:  Recenti Prog Med       Date:  1990-12

Review 3.  Mechanisms of resistance of malaria parasites to antifolates.

Authors:  Aric Gregson; Christopher V Plowe
Journal:  Pharmacol Rev       Date:  2005-03       Impact factor: 25.468

4.  Molecular assays for surveillance of antifolate-resistant malaria.

Authors:  J G Kublin; R S Witzig; A H Shankar; J Q Zurita; R H Gilman; J A Guarda; J F Cortese; C V Plowe
Journal:  Lancet       Date:  1998-05-30       Impact factor: 79.321

5.  Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.

Authors:  C V Plowe; J F Cortese; A Djimde; O C Nwanyanwu; W M Watkins; P A Winstanley; J G Estrada-Franco; R E Mollinedo; J C Avila; J L Cespedes; D Carter; O K Doumbo
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

6.  Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins.

Authors:  P Wang; C S Lee; R Bayoumi; A Djimde; O Doumbo; G Swedberg; L D Dao; H Mshinda; M Tanner; W M Watkins; P F Sims; J E Hyde
Journal:  Mol Biochem Parasitol       Date:  1997-11       Impact factor: 1.759

7.  Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study.

Authors:  S Biswas; A Escalante; S Chaiyaroj; P Angkasekwinai; A A Lal
Journal:  Trop Med Int Health       Date:  2000-10       Impact factor: 2.622

Review 8.  Current scenario of malaria in India.

Authors:  V P Sharma
Journal:  Parassitologia       Date:  1999-09

9.  Progressive increase in point mutations associated with chloroquine resistance in Plasmodium falciparum isolates from India.

Authors:  Pooja Mittra; Sumiti Vinayak; Hina Chandawat; Manoj K Das; Neeru Singh; Sukla Biswas; Vas Dev; Ashwani Kumar; Musharraf A Ansari; Yagya D Sharma
Journal:  J Infect Dis       Date:  2006-03-21       Impact factor: 5.226

10.  Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance.

Authors:  Anwar Ahmed; Deepak Bararia; Sumiti Vinayak; Mohammed Yameen; Sukla Biswas; Vas Dev; Ashwani Kumar; Musharraf A Ansari; Yagya D Sharma
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

View more
  18 in total

1.  Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.

Authors:  Mohammad Tauqeer Alam; Hema Bora; Praveen K Bharti; Muheet A Saifi; Manoj K Das; Vas Dev; Ashwani Kumar; Neeru Singh; Aditya P Dash; Brahmananda Das; Yagya D Sharma
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

2.  Multiple origins of Plasmodium falciparum dihydropteroate synthetase mutant alleles associated with sulfadoxine resistance in India.

Authors:  Vanshika Lumb; Manoj K Das; Neeru Singh; Vas Dev; Wajihullah Khan; Yagya D Sharma
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

3.  Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.

Authors:  Sweta Mishra; Praveen K Bharti; Man M Shukla; Nazia A Ali; Sher S Kashyotia; Avdhesh Kumar; Akshay C Dhariwal; Neeru Singh
Journal:  Pathog Glob Health       Date:  2017-05-26       Impact factor: 2.894

Review 4.  Molecular assays for determining sulphadoxine-pyrimethamine drug resistance in India: a systematic review.

Authors:  Shradha Bhullar; Neelima Mishra
Journal:  Parasitol Res       Date:  2022-08-18       Impact factor: 2.383

5.  Characteristics of genetic hitchhiking around dihydrofolate reductase gene associated with pyrimethamine resistance in Plasmodium falciparum isolates from India.

Authors:  Vanshika Lumb; Manoj K Das; Neeru Singh; Vas Dev; Yagya D Sharma
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

6.  Origin and evolution of sulfadoxine resistant Plasmodium falciparum.

Authors:  Sumiti Vinayak; Md Tauqeer Alam; Tonya Mixson-Hayden; Andrea M McCollum; Rithy Sem; Naman K Shah; Pharath Lim; Sinuon Muth; William O Rogers; Thierry Fandeur; John W Barnwell; Ananias A Escalante; Chansuda Wongsrichanalai; Frederick Ariey; Steven R Meshnick; Venkatachalam Udhayakumar
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

7.  Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009-2010.

Authors:  Neelima Mishra; Jai Prakash Narayan Singh; Bina Srivastava; Usha Arora; Naman K Shah; S K Ghosh; R M Bhatt; S K Sharma; M K Das; Ashwani Kumar; Anupkumar R Anvikar; Kamlesh Kaitholia; Ruchi Gupta; G S Sonal; A C Dhariwal; Neena Valecha
Journal:  Bull World Health Organ       Date:  2012-10-31       Impact factor: 9.408

8.  Extensive genetic diversity in the Plasmodium falciparum Na+/H+ exchanger 1 transporter protein implicated in quinine resistance.

Authors:  Sumiti Vinayak; Mohammad Tauqeer Alam; Mala Upadhyay; Manoj K Das; Vas Dev; Neeru Singh; Aditya P Dash; Yagya D Sharma
Journal:  Antimicrob Agents Chemother       Date:  2007-10-08       Impact factor: 5.191

9.  Artemisinin combination therapy fails even in the absence of Plasmodium falciparum kelch13 gene polymorphism in Central India.

Authors:  Sabyasachi Das; Amrita Kar; Subhankar Manna; Samaresh Mandal; Sayantani Mandal; Subhasis Das; Bhaskar Saha; Amiya Kumar Hati
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

10.  Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.

Authors:  Samir Ranjitkar; Mette L Schousboe; Thomas Thyge Thomsen; Madhav Adhikari; Christian M O Kapel; Ib C Bygbjerg; Michael Alifrangis
Journal:  Malar J       Date:  2011-04-01       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.